2-Day In-Person Seminar by Ex-FDA Official

FDA's GMP Expectations for Phase I and First-in-Man Clinical Trials

BY: Peggy J. Berry,

MBA, RAC, President & CEO, Synergy Consulting (Ex-FDA Official)

March 14-15, 2019
San Diego, CA
  • Course Description
  • Agenda
  • Speaker
  • Price/Register
  • Venue/Hotel
  • Testimonials
  • Partners/Sponsors
  • Local Attractions

Because a phase 1 clinical trial initially introduces an investigational new drug into human subjects, appropriate CGMP help ensure subject safety. It is important to implement quality control (QC) principles to the manufacture of phase 1 investigational drugs (i.e., interpreting and implementing CGMP consistent with good scientific methodology), which foster CGMP activities that are more appropriate for phase 1 clinical trials, improve the quality of phase 1 investigational drugs, and facilitate the initiation of investigational clinical trials in humans while continuing to protect trial subjects.

The following steps to establish the appropriate manufacturing environment for phase 1 investigational drugs should be taken:

  • A comprehensive and systematic evaluation of the manufacturing setting (i.e., product environment, equipment, process, personnel, materials) to identify potential hazards
  • Appropriate actions prior to and during manufacturing to eliminate or mitigate potential hazards to safeguard the quality of the phase 1 investigational drug

Review the FDA recommendations and requirements for implementing a compliant program for the phase 1 clinical program.

The following topics will be discussed to provide the foundation and basis for advancing drugs into clinical development from research and providing required information to the FDA regarding these products.

  • Overview of Good Manufacturing Practices
  • GMP Requirements for a Phase 1 Study
    • Personnel
    • QC Function
    • Facility and Equipment
    • Control of components, containers and closures
    • Manufacturing & Records
    • Laboratory Controls
  • Vendor selection & management
  • Process Validation
  • Special Considerations
    • Multi-product facilities
    • Biologics
    • Sterile products
    • Combination products
  • Providing relevant information in the IND application

Course benefit:

This workshop will review the current regulations, guidance documents for early stage manufacturing and GMPs in detail. Regulatory strategies and logistical considerations for early development stage product, including vendor selection and management, stability, labeling, and documentation requirements will also be reviewed and explored.

Learning Objectives:

To gain an understanding of the requirements for drugs entering into phase 1 clinical development and the minimum FDA requirements for phase I GMPs. To learn practical applications for implementing manufacturing and quality strategies to meet FDA requirements.

Areas Covered:

Day 1 Topics

  • Overview of GMP requirements
  • GMP Requirements for a Phase 1 Study
  • Personnel documentation and requirements
  • QC Function procedures and requirements
  • Facility and Equipment requirements
  • Control of components, containers and closures – methods and specs
  • Manufacturing & Records during phase 1 studies with an eye toward later development

Day 2 Topics

  • Vendor selection & management
  • Process Validation to conduct for phase 1 clinical supply process
  • Specific requirements for various types of products: biologics, combinations, sterile products
  • Multi-product facilities considerations
  • Preparing relevant SOPs for early stage development
  • Providing relevant information in the IND application
Who will Benefit:
  • Directors
  • Manager
  • Supervisors
  • Lead workers in Regulatory Affairs Quality Assurance and Quality Control
  • Workers who will prepare GMP documents for early phase products
  • Workers who will review GMP documents for early phase products
Day 01(8:30 AM - 4:00 PM)
  • 8:30 – 9:00 AM: Registration
  • 9:00 – 10:30 AM: Good Manufacturing Practices & Phase 1 Requirements
    • Core principles of GMP
    • Detailed review of FDA phase 1 guidance document
  • 10:30 – 10:45 AM: Break
  • 10:45 – 12:30 noon: Good Manufacturing Practices & Phase 1 Requirements, continued
    • Acceptable practices and practical tips
    • GMP requirements for exploratory clinical studies
  • 12:30 – 1:15 PM: Lunch
  • 1:15 – 2:45 PM: Good Manufacturing Practices & Phase 1 Requirements, continued
    • Personnel documentation and requirements
    • Facility & equipment requirements
    • Control of components
    • Specific requirements for specialty products
  • 2:45 – 3:00 PM: Break
  • 3:00 – 4:00 PM: Vendor Selection and Management
    • Planning for the early stage with an eye towards large scale manufacturing
    • Vendor management
    • Raw material handling issues for early stage products
Day 02(8:30 AM - 4:00 PM)
  • 8:30 – 10:00 AM: Overview of INDs Requirements & Expectations
    • FDA requirements for an IND submission
    • Expectations upon IND review
    • Format and content of the CMC section of an IND
  • 10:00 – 10:15 AM: Break
  • 10:15 – 12:00 noon: Overview of INDs Requirements & Expectations, continued
    • Characterization of the active ingredient and finished product
    • Various kinds of products: drugs, biologics, botanicals, diagnostics, medical devices
    • Manufacturing facility, personnel and equipment requirements
  • 12:00 – 12:45 PM: Lunch
  • 12:45 – 2:15 PM: Process Validation
    • Introduction to process validation for early stage manufacturers
    • Process validation reports and other documentation
  • 2:15 – 2:30 PM: Break
  • 2:30 – 4:00 PM: Creating SOPs Across all Stages of Development
    • What SOPs are required during early clinical development
    • When do additional SOPs need to be created
    • Ensuring that appropriate SOPs are in place for contractors
    • SOP processes and creation
    • QC function and responsibilities
Robert J. Russell
Peggy J. Berry MBA, RAC,President & CEO, Synergy Consulting (Ex-FDA Official)

Peggy J. Berry, MBA, RAC, is the President & CEO at Synergy Consulting where she provides consulting services to companies in all aspects of drug development. She also provides group and one-on-one training in drug development, regulatory affairs and project management topics. Prior to founding Synergy Consulting in 2015, she was Vice President of Regulatory Affairs at Insmed (2/2015-5/2015) where she was responsible for the development and implementation of global regulatory strategies and the management and oversight of the regulatory affairs department. Prior to Insmed, she was Vice President of Regulatory Affairs and Quality at Amarin (3/2009-2/2014). She has also held a variety of senior level positions at Dyax (5/2006-3/2009), MGI Pharma (now Eisai; 7/2005-5/2006), AstraZeneca (10/2001-7/2005), and Dey Pharma (now Mylan; 12/1997-10/2001). She has also held Regulatory Affairs roles within two clinical contract research organizations (ILEX Oncology and Cato Research Ltd; 1992-1997) and has worked in review divisions at the FDA (1985-1992). In addition, Ms. Berry consults for a number of companies in the regulatory and quality area, conducts a number of training courses, and is active in the Regulatory Affairs Professionals Society. She is the editor of the 2010 book "Choosing the Right Regulatory Career" (RAPS, MD) and author of the 2011 book "Communication & Negotiation" (RAPS, MD).

Register Now

Online using Credit card

$1,299.00

Seminar One Registration

March 14-15, 2019, San Diego, CA
(Registrations till December 21, 2018 - $1299)
(Registrations after December 21, 2018 - $1499)


Early bird seats are limited and based on first-come, first-serve.

Your registration fee includes the workshop, all course materials and lunch.
For discounts on multiple registrations, contact customer care at +1-888-771-6965.

Other Registration Options

By order form / PO#

Payment Modes

By Check -

To pay by check please contact customercare@fdatrainingalert.com

By Wire -

Register / Pay by Wire TransferPlease contact us at +1-888-771-6965 to get details of wire transfer option.

Terms & Conditions to Register for the Seminar/Conference/Event »

Terms & Conditions to register for the Seminar/Conference/Event

Your Registration for the seminar is subject to following terms and conditions. If you need any clarification before registering for this seminar please call us @ +1-888-771-6965 or email us @ customercare@fdatrainingalert.com

Payment:
Payment is required before 2 days of the date of the conference. We accept American Express, Visa and MasterCard. Make checks payable to MetricStream Inc. ( our parent company)

Cancellations and Substitutions:
Written cancellations through fax or email (from the person who has registered for this conference) received at least 10 calendar days prior to the start date of the event will receive a refund — less a $300 administration fee. No cancellations will be accepted — nor refunds issued — within 10 calendar days from the start date of the event.

On request by email or fax (before the seminar) a credit for the amount paid minus administration fees ($300) will be transferred to any future FDATrainingAlert event and a credit note will be issued.

Substitutions may be made at any time. No-shows will be charged the full amount.

We discourage onsite registrations, however if you wish to register onsite payment to happen through credit card immediately or check to be submitted onsite. Conference material will be given on the spot if it is available after distributing to other attendees. In case it is not available we will send the material after the conference is over.

In the event FDATrainingAlert cancels the seminar, FDATrainingAlert is not responsible for any airfare, hotel, other costs or losses incurred by registrants. Some topics and speakers may be subject to change without notice.

Attendance confirmation and Documents to carry to the seminar venue:
After we receive the payment from the registered attendee an electronic event pass will be sent to the email address associated with the registrant before 5 working days from the seminar date. Please bring the pass to the venue of the event.

Conference photograph / video:
By registering and attending FDATrainingAlert conference you agree to have your photographs or videos taken at the conference venue and you do not have any objections to use these photos and videos by FDATrainingAlert for marketing, archiving or any other conference related activities. You agree to release FDATrainingAlert for any kind of claims arising out of copyright or privacy violations.

Disclaimer: Directions to the venue above have been taken from the hotel website. Attendees are advised to check with the hotel for confirmation of these directions before starting for the venue. ComplianceOnline is not responsible for any inaccuracies in the same.

See What People Say About Us

I enjoyed the practical answers and lessons learned as shared by the presenter. Grateful for the sharing of presentation material (soft copy). Thanks to FDATrainingAlert for timely response and communication. Variety of choices is extensive good and easy to register.

Manager, Process Optimization,

Prolong Pharmaceuticals, LLC

Excellent instructor and he was easy to follow and I like the thorough and thoughtful answers of my questions.

Senior Scientist,

CCS Associates

Instructor is very knowledgeable and good in explaining regs and guidance. Information provided along with soft copy of slide is a great idea and very helpful.

Sr. QA Manager,

Theravance

Overall a good general overview. The amount of interaction between the participants and presenter was good.

Asst. Director QA, Clinical Packaging,

Abbott Labs

GMP expectations was the most valuable topic for me. Face to face interaction and networking was good.

Director of Pharmacy,

Pfizer New Haven Clinical Research Unit

Speaker’s knowledge was higher than I had hoped.

Director,

BioMed IRB

For me the whole event was very good. I had no knowledge of the topic prior to this seminar. The presentation was excellent and the speaker was very knowledgeable and respectful.

Quality Assurance Specialist,

Therapure Biopharma Inc.

I had registered for a seminar but unfortunately I was not able to attend. The company was very understanding and extremely helpful. I plan on attending a future event soon.

Director of Regulatory Affairs,

Nickell Physician & Pharmacy Services

Partners/Sponsors

We are pleased to offer several exhibitor, sponsorship and media partnership options designed to maximize your company's exposure and networking opportunities before, during and after the event.

Benefits of becoming a Sponsor/Exhibitor/Media Partner:

  • Logo on website, marketing email, branding materials & the registration booth
  • Exhibit Space
  • Free event pass
  • Speaking opportunity
  • Social media campaign

For more details and other sponsorship options at this event, please contact Event Manager: customercare@fdatrainingalert.com or call: +1-650-238-9656

Media Partner:

Media Partner

Local Attractions of San Diego, CA

San Diego Cabrillo National Monument San Diego Cabrillo National Monument

Board a luxurious Think Escape party bus or limo and be whisked away to San Francisco's hottest nightclubs where VIP treatment brings all party bus guests to the front of the line. Board a luxurious Think Escape party bus or limo and be whisked away to San Francisco's hottest nightclubs where VIP treatment brings all party bus guests to the front of the line. Board a luxurious Think Escape party bus or limo and be whisked away to San Francisco's hottest nightclubs where VIP treatment brings all party bus guests to the front of the line.

Sea Creatures at Birch Aquarium Sea Creatures at Birch Aquarium

Birch Aquarium is north of San Diego in La Jolla. It's not as big as some of the other aquariums in California or as flashy as the big sea-themed park down the road, but instead just right, filled with interesting exhibits and home to leafy sea dragons like the one above, creatures so improbably they look more like something from a children's book than from the ocean.

Legoland Legoland

Legoland theme park takes its inspiration from Lego toys, those cute little bricks that snap together to build all kinds of fun things. It's one of several Legolands worldwide.

San Diego Zoo Safari Park San Diego Zoo Safari Park

The San Diego Zoo's sister park offers a different kind of animal experience. Its name (Safari Park) is the clue and it indeed offers a more safari-like experience. Lots of large animals live in the same big, open areas here - predators kept away from prey, but otherwise much as they would in their natural habitat.

Coronado Island Coronado Island

Coronado isn't really an island but a peninsula - a fact that doesn't get in the way of the name most people use for it. Whatever you call it, it's on a slender strip of land between the San Diego Bay and the Pacific Ocean, barely a few blocks wide. What it lacks in size it makes up for in fun, with a beach that's been named among the best in the country, a classic hotel and a compact, lively little downtown. Coronado's laid-back temperament makes a nice break from the busier parts of San Diego across the water.

Balboa Park Balboa Park

Originally built for temporary use during the 1915-16 Panama-California Exposition in San Diego, Balboa Park boasts buildings beautiful enough to be considered attractions in themselves, especially if you're a photographer. They're surrounded by trees, lawns and fountains, but that's only the beginning.

You Recently Viewed